J. Judice
Algemeen Directeur bij DICE THER
Actieve functies van J. Judice
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DICE THER | Oprichter | - | - |
| Algemeen Directeur | 01-08-2013 | - | |
| Directeur/Bestuurslid | - | - | |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Algemeen Directeur | - | - |
| Oprichter | - | - | |
| President | - | - | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Algemeen Directeur | 01-01-2013 | - |
| Oprichter | 01-01-2013 | - |
Loopbaan van J. Judice
Eerdere bekende functies van J. Judice
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Directeur/Bestuurslid | 30-06-2014 | 20-04-2015 |
| Hoofd Techniek/Wetenschap/O&O | 30-06-2014 | - | |
| Oprichter | 01-12-2012 | 20-04-2015 | |
| ACHAOGEN | Directeur/Bestuurslid | 19-01-2011 | 01-10-2011 |
| Algemeen Directeur | 01-06-2002 | 01-10-2011 | |
| Hoofd Techniek/Wetenschap/O&O | 01-06-2002 | 01-10-2011 | |
| Oprichter | 01-06-2002 | 07-03-2011 | |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01-09-1997 | 01-03-2002 |
| INNOVIVA, INC. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Opleiding van J. Judice
| Texas A&M University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 11 |
Operationeel
| Founder | 5 |
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
DiCE Molecules, Inc.
DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Technology Services |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
